Sticky science: new pain patch put to the adhesion test
NCT ID NCT07307794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new medicated patch (TK-254RX) that delivers the pain reliever esflurbiprofen through the skin. Researchers want to see how well the patch stays on over time in 90 healthy adults aged 18 to 64. They will also check for any side effects and measure how much medicine is left in the used patch. This is an early-stage (Phase 1) study, so it focuses on safety and performance, not on treating a disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Deutsche Sporthochschule Köln
RECRUITINGAm Sportpark Muengersdorf 6, Clogne, 50933, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates